What were the results of this study?
This is a summary of the main results from this study overall. The results each participant had might be different and are not in this summary. A full list of the questions that researchers wanted to answer can be found on the websites listed at the end of this summary. When a full report of the study results is available, it can also be found on these websites.
Researchers look at the results of many studies to decide which treatments work best and are safest. Other studies may provide new information or different results. Always talk to a doctor before making any treatment changes.
The results below include only the participants who took acalabrutinib for more than 6 months. One participant from the relapsed/refractory group was not included for this reason.
How many participants responded to treatment with acalabrutinib?
Overall, the researchers found that after taking acalabrutinib:
- 90.3% of the participants in the relapsed/refractory group responded to treatment with acalabrutinib. This was 28 out of 31 participants.
- 87.5% of the participants in the treatment-na√Øve group responded to treatment with acalabrutinib. This was 14 out of 16 participants.